Franklin Resources Inc Invitae Corp Transaction History

Franklin Resources Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $163,493 - $318,867	-11,122 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $270,375 - $373,699	11,122 New	11,122 $316,000
Q2 2021 Aug 13, 2021	SELL	$26.09 - $40.4 $26.8 Million - $41.5 Million	-1,026,413 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$33.06 - $56.93 $3.02 Million - $5.2 Million	-91,337 Reduced 8.17%	1,026,413 $39.2 Million
Q4 2020 Feb 10, 2021	BUY	$39.09 - $57.4 $29.9 Million - $43.9 Million	764,266 Added 216.21%	1,117,750 $46.7 Million
Q3 2020 Nov 12, 2020	BUY	$28.43 - $44.67 $10 Million - $15.8 Million	353,484 New	353,484 $15.3 Million
Q2 2019 Aug 14, 2019	SELL	$17.37 - $26.27 $441,198 - $667,258	-25,400 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$10.65 - $25.75 $270,510 - $654,050	25,400 New	25,400 $595,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.